Save your place

Sign in to WhoBought

Please try again later.

CG Oncology, Inc. Common stock (CGON) institutional ownership

Latest close $70.19 Jul 20, 2026
Market cap$2.0B 52-week range SectorHealthcare
Funds holding · Q1 2026
219
reported CGON position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
135 buyers · 84 sellers

CG Oncology, Inc. Common stock (CGON) price and institutional activity

Dates

Q1 2026

$0 bought by 135 investors
T. Rowe Price Investment Management, Inc.Rtw Investments, LP +133 more
$0 sold by 84 investors
Seven Fleet Capital Management LPPictet Asset Management Holding SA +82 more
Bought Sold Totals per quarter; hover a bar for the names.

CG Oncology, Inc. Common stock (CGON) institutional activity · 219

Investor Type Est. change Change Δ Own Date
T. Rowe Price Investment Management, Inc. · Added
Change +6.3M Date Q1 2026
T. Rowe Price Investment Management, Inc. Added· Q1 2026 +6.3M Q1 2026
Rtw Investments, LP · Added
Change +5.0M Date Q1 2026
Rtw Investments, LP Added· Q1 2026 +5.0M Q1 2026
Seven Fleet Capital Management LP · Reduced
Change −1.4M Date Q1 2026
Seven Fleet Capital Management LP Reduced· Q1 2026 −1.4M Q1 2026
Driehaus Capital Management LLC · New
Change +1000K Date Q1 2026
Driehaus Capital Management LLC New· Q1 2026 +1000K Q1 2026
Pictet Asset Management Holding SA · Reduced
Change −952K Date Q1 2026
Pictet Asset Management Holding SA Reduced· Q1 2026 −952K Q1 2026
Kynam Capital Management, LP · Exited
Change −946K Δ Own −100.0% Date Q1 2026
Kynam Capital Management, LP Exited· Q1 2026 −946K −100.0% Q1 2026
Braidwell LP · Reduced
Change −886K Date Q1 2026
Braidwell LP Reduced· Q1 2026 −886K Q1 2026
Farallon Capital Management LLC · Added
Change +666K Δ Own +8325.0% Date Q1 2026
Farallon Capital Management LLC Added· Q1 2026 +666K +8325.0% Q1 2026
Wellington Management Group LLP · Reduced
Change −629K Δ Own −10.5% Date Q1 2026
Wellington Management Group LLP Reduced· Q1 2026 −629K −10.5% Q1 2026
UBS Group AG · Reduced
Change −612K Date Q1 2026
UBS Group AG Reduced· Q1 2026 −612K Q1 2026
Orbimed Advisors LLC · Reduced
Change −568K Date Q1 2026
Orbimed Advisors LLC Reduced· Q1 2026 −568K Q1 2026
FMR LLC · Reduced
Change −533K Δ Own −12.4% Date Q1 2026
FMR LLC Reduced· Q1 2026 −533K −12.4% Q1 2026
Citadel Advisors LLC Reduced· Q1 2026 −508K −74.6% Q1 2026
Fisher Asset Management, LLC New· Q1 2026 +465K Q1 2026
Adage Capital Partners Gp, L.L.C. · New
Change +400K Date Q1 2026
Adage Capital Partners Gp, L.L.C. New· Q1 2026 +400K Q1 2026
Data through Q1 2026 · filed Jun 4, 2026
15 of 219

Famous investor activity in CG Oncology, Inc. Common stock (CGON)

CG Oncology, Inc. Common stock (CGON) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Post Leonard E. · Director Sell −$71K
Price $71.17 Qty −1K Owned 0 ΔOwn −100.0% Trade date Jul 15, 2026 Filed date Jul 17, 2026
Post Leonard E. Director Sell $71.17 −1K −$71K 0 −100.0% Jul 15, 2026 Jul 17, 2026
Post Leonard E. · Director 2 operations 0
Price $0.60 Owned 105K Trade date Jul 15, 2026 Filed date Jul 17, 2026
Post Leonard E. Director 2 operations $0.60 0 105K Jul 15, 2026 Jul 17, 2026
Mulay James · Director Sell −$1.8M
Price $75.16 Qty −24K Owned 0 ΔOwn −100.0% Trade date Jul 10, 2026 Filed date Jul 14, 2026
Mulay James Director Sell $75.16 −24K −$1.8M 0 −100.0% Jul 10, 2026 Jul 14, 2026
Mulay James · Director 2 operations 0
Price $26.63 Owned 0 Trade date Jul 10, 2026 Filed date Jul 14, 2026
Mulay James Director 2 operations $26.63 0 0 Jul 10, 2026 Jul 14, 2026
Liu Brian Guan-Chyun · Director Buy +$25M
Price $66.87 Qty +371K Owned 1.9M ΔOwn +24.5% Trade date Jun 25, 2026 Filed date Jun 29, 2026
Liu Brian Guan-Chyun Director Buy $66.87 +371K +$25M 1.9M +24.5% Jun 25, 2026 Jun 29, 2026
Post Leonard E. · Director Sell −$350K
Price $70.00 Qty −5K Owned 0 ΔOwn −100.0% Trade date Jun 24, 2026 Filed date Jun 25, 2026
Post Leonard E. Director Sell $70.00 −5K −$350K 0 −100.0% Jun 24, 2026 Jun 25, 2026
Post Leonard E. · Director 2 operations 0
Price $0.60 Owned 106K Trade date Jun 24, 2026 Filed date Jun 25, 2026
Post Leonard E. Director 2 operations $0.60 0 106K Jun 24, 2026 Jun 25, 2026
Post Leonard E. · Director Sell −$325K
Price $65.00 Qty −5K Owned 0 ΔOwn −100.0% Trade date Jun 22, 2026 Filed date Jun 23, 2026
Post Leonard E. Director Sell $65.00 −5K −$325K 0 −100.0% Jun 22, 2026 Jun 23, 2026
Post Leonard E. · Director 2 operations 0
Price $0.60 Owned 111K Trade date Jun 22, 2026 Filed date Jun 23, 2026
Post Leonard E. Director 2 operations $0.60 0 111K Jun 22, 2026 Jun 23, 2026
Mulay James · Director 2 operations −$118K
Price $60.12 Qty −2K Owned 0 Trade date Jun 15, 2026 Filed date Jun 16, 2026
Mulay James Director 2 operations $60.12 −2K −$118K 0 Jun 15, 2026 Jun 16, 2026
Mulay James · Director 4 operations 0
Price $3.72–$12.59 Owned 3K Trade date Jun 15, 2026 Filed date Jun 16, 2026
Mulay James Director 4 operations $3.72–$12.59 0 3K Jun 15, 2026 Jun 16, 2026
Liu Brian Guan-Chyun · Director Grant (A) 9K
Owned 9K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Liu Brian Guan-Chyun Director Grant (A) 9K 9K Jun 4, 2026 Jun 5, 2026
Tong Victor Edward Jr · Director Grant (A) 9K
Owned 9K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Tong Victor Edward Jr Director Grant (A) 9K 9K Jun 4, 2026 Jun 5, 2026
Mulay James · Director Grant (A) 9K
Owned 9K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Mulay James Director Grant (A) 9K 9K Jun 4, 2026 Jun 5, 2026
Rossi Christina · Director Grant (A) 9K
Owned 9K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Rossi Christina Director Grant (A) 9K 9K Jun 4, 2026 Jun 5, 2026
15 of 57
15 of 57 Sign in to continue to older insider transactions.

CG Oncology, Inc. Common stock (CGON) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Rtw Investments, LP 7.0M
% of shares outstanding 8.3% Filing date May 15, 2026
Rtw Investments, LP 7.0M 8.3% May 15, 2026
T. Rowe Price Investment Management, Inc. 6.7M
% of shares outstanding 8.0% Filing date May 15, 2026
T. Rowe Price Investment Management, Inc. 6.7M 8.0% May 15, 2026
Vanguard Group Inc 5.1M
% of shares outstanding 7.6% Filing date Nov 12, 2024
Vanguard Group Inc 5.1M 7.6% Nov 12, 2024
Decheng Capital Global Life Sciences Fund Iv, L.P. 5.0M
% of shares outstanding 7.4% Filing date Apr 9, 2024
Decheng Capital Global Life Sciences Fund Iv, L.P. 5.0M 7.4% Apr 9, 2024
Decheng Capital Global Life Sciences Fund Iv, L.P. 4.6M
% of shares outstanding 6.9% Filing date Feb 8, 2024
Decheng Capital Global Life Sciences Fund Iv, L.P. 4.6M 6.9% Feb 8, 2024
Tcg Crossover Gp I, LLC 3.6M
% of shares outstanding 5.4% Filing date Feb 9, 2024
Tcg Crossover Gp I, LLC 3.6M 5.4% Feb 9, 2024
Blackrock, Inc. 3.6M
% of shares outstanding 5.3% Filing date Nov 8, 2024
Blackrock, Inc. 3.6M 5.3% Nov 8, 2024
Kissei Pharmaceutical Co., Ltd. 3.5M
% of shares outstanding 5.3% Filing date Mar 14, 2024
Kissei Pharmaceutical Co., Ltd. 3.5M 5.3% Mar 14, 2024
8 of 11

CG Oncology, Inc. Common stock (CGON) ownership FAQ

Who owns CGON?

219 reporting institutions disclosed CGON position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.